Apotex Health Corp. and backers raised C$1.3 billion ($932 million) in a Toronto IPO priced at C$24 per share, the high end of the range. The generic drug maker sold 35.4 million shares, and selling holders divested about 18.8 million shares. It is Canada's largest IPO since 2021.
Tap to vote and see what everyone thinks.